| Value | ₹10.01 Cr |
|---|
NSE filing, NSE: NATCAPSUQ. Summary written from the filing by ALFA Finder's alert engine.
Natural Capsules Ltd: key numbers
- Share price
- ₹137.78
- Market cap
- ₹143.4 Cr
- Revenue (annual)
- ₹187.2 Cr
- Net profit (annual)
- ₹-24.66 Cr
- P/E (TTM)
- -6.7×Sector 37.9×
- Promoter holding
- 50.92%+0.00% QoQ
- FII holding
- 0.08%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Natural Capsules Ltd
All →Natural Capsules Annual General Meeting
Natural Capsules Ltd dispatched a corrigendum to its upcoming EGM notice, revising the issue price and quantity for the proposed preferential allotment of shares and warrants.
Natural Capsules Fund Raise of ₹10.01 Cr
Natural Capsules Limited approved a revised preferential issue of 1,12,500 equity shares and 4,50,000 convertible warrants. The total aggregate fund raise is valued at Rs. 10.01 Crore.
- Value
- ₹10.01 Cr
Natural Capsules Board Meeting Date
Natural Capsules Limited is holding a board meeting at shorter notice on September 02, 2026, to revise the issue price and quantity for its proposed preferential issue.
Natural Capsules Annual General Meeting
Natural Capsules Limited has issued a notice for an EGM to approve a Rs. 10.00 Crore preferential allotment of equity shares and warrants to a promoter.
- Value
- ₹10.00 Cr
Natural Capsules Investor Presentation: Key Takeaways
NCL reported Q1FY27 revenue of ₹48.71 Cr (+8% Y-o-Y) with EBITDA at ₹1.12 Cr. Strategy focuses on scaling steroidal API volumes and HPMC line conversions to optimize capacity.
Natural Capsules Results Update
Natural Capsules Limited announced its Q1FY27 financial results. The company highlighted operational performance, market demand, and new contract manufacturing agreements for its business segments.
Other preferential issue announcements
All →5Paisa Capital Preferential Issue
5paisa allotted 20,50,588 preferential equity shares at ₹380 each for Giskard Datatech shares. The allotment aggregates ₹77.92 Crore, paid via share swap.
- Value
- ₹77.92 Cr
Stellant Securities (India) Preferential Issue
Stellant Securities allotted 678,388 equity shares and 166,200 warrants on a preferential basis at Rs 602 each. Total cash consideration is about Rs 50.84 Cr, with 25% received on the warrants.
- Value
- ₹50.84 Cr
Balaji Phosphates Preferential Issue
Balaji Phosphates filed a revised valuation report for in-principle approval of its equity shares and convertible warrants issue. The filing responds to an NSE letter dated November 4, 2026, with no amount stated.
Rossell Techsys Preferential Issue
Rossell Techsys allotted 25,72,898 preferential shares to SBI funds for Rs.299.99 Crore. The allotment is at Rs.1,166 per share with two allottees.
- Value
- ₹300.0 Cr
Datakosa Preferential Issue
Datakosa received BSE listing approval for 20,58,822 equity shares issued on a preferential basis to non-promoters at ₹17 per share. The approval is a post-allotment listing step in a preferential issue.
- Value
- ₹3.50 Cr
Jetking Infotrain Preferential Issue
Jetking Infotrain withdrew its proposed ₹11.50 Crore preferential issue due to prevailing market conditions. It also withdrew the pending BSE in-principle listing application.
- Value
- ₹11.50 Cr